Bioethics LTD 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Bioethics, Ltd., a long-standing shell company, reported a significant increase in net losses and a worsening working capital deficit for fiscal year 2024, compounded by the expiration of a key merger agreement.
OTC.Pink
Bioethics, Ltd., a shell company, reported its 2023 annual results, highlighting its ongoing search for a business acquisition opportunity and its financial position.